{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T13:16:40Z","timestamp":1774531000655,"version":"3.50.1"},"reference-count":144,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,4,8]],"date-time":"2022-04-08T00:00:00Z","timestamp":1649376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,4,8]],"date-time":"2022-04-08T00:00:00Z","timestamp":1649376000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Peter the Great St.Petersburg Polytechnic University","award":["Academic Excellence Project 5-100"],"award-info":[{"award-number":["Academic Excellence Project 5-100"]}]},{"name":"Vavilov Institute of General Genetics RAS"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infect Agents Cancer"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>In previous publications, the author developed the theory of<jats:italic>carcino-evo-devo<\/jats:italic>, which predicts that evolutionarily novel organs should recapitulate some features of tumors in their development.<\/jats:p><\/jats:sec><jats:sec><jats:title>Main text<\/jats:title><jats:p>Mammalian adipose is currently recognized as a multi-depot metabolic and endocrine organ consisting of several adipose tissues. Although lipid-storing cells and proteins are ancient, the adipose organ as a whole is evolutionarily novel to mammals. The adipose expansion has remarkable similarities with the growth of solid tumors. These similarities are the following: (1) The capability to unlimited expansion; (2) Reversible plasticity; (3) Induction of angiogenesis; (4) Chronic inflammation; (5) Remodeling and disfunction; (6) Systemic influence on the organism; (7) Hormone production; (8) Production of miRNAs that influence other tissues; (9) Immunosuppression; (10) DNA damage and resistance to apoptosis; (11) Destructive infiltration in other organs and tissues. These similarities include the majority of \u201challmarks of cancer\u201d. In addition, lipomas are the most frequent soft tissue tumors, and similar drugs may be used for the treatment of obesity and cancer by preventing infiltration. This raises the possibility that obesity, at least in part, may represent an oncological problem. The existing similarities between adipose and tumors suggest the possible evolutionary origin of mammalian adipose from some ancestral benign mesenchymal hereditary tumors. Indeed, using a transgenic inducible zebrafish tumor model, we described many genes, which originated in fish and were expressed in fish tumors. Their human orthologs<jats:italic>LEP<\/jats:italic>,<jats:italic>NOTCH1<\/jats:italic>,<jats:italic>SPRY1<\/jats:italic>,<jats:italic>PPARG<\/jats:italic>,<jats:italic>ID2<\/jats:italic>, and<jats:italic>CIDEA<\/jats:italic>acquired functions connected with the adipose organ. They are also involved in tumor development in humans.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>If the hypothesis of the evolutionary origin of the adipose organ from the ancestral hereditary tumor is correct, it may open new opportunities to resolve the oncological problem and the problem of the obesity epidemic. New interventions targeting<jats:italic>LEP<\/jats:italic>,<jats:italic>NOTCH1<\/jats:italic>,<jats:italic>SPRY1<\/jats:italic>,<jats:italic>PPARG<\/jats:italic>,<jats:italic>ID2<\/jats:italic>, and<jats:italic>CIDEA<\/jats:italic>gene network, in addition to what already is going on, can be designed for treatment and prevention of both obesity and tumors.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s13027-022-00423-5","type":"journal-article","created":{"date-parts":[[2022,4,8]],"date-time":"2022-04-08T12:02:58Z","timestamp":1649419378000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Mammalian tumor-like organs. 2. Mammalian adipose has many tumor features and obesity is a tumor-like process"],"prefix":"10.1186","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4611-1534","authenticated-orcid":false,"given":"A. P.","family":"Kozlov","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,4,8]]},"reference":[{"key":"423_CR1","volume-title":"Evolution by tumor neofunctionalization: the role of tumors in the origin of new cell types, tissues, and organs","author":"AP Kozlov","year":"2014","unstructured":"Kozlov AP. Evolution by tumor neofunctionalization: the role of tumors in the origin of new cell types, tissues, and organs. Amsterdam: Elsevier; 2014."},{"key":"423_CR2","doi-asserted-by":"publisher","first-page":"65","DOI":"10.32607\/20758251-2019-11-4-65-72","volume":"11","author":"AP Kozlov","year":"2019","unstructured":"Kozlov AP. The role of heritable tumors in evolution of development: a new theory of carcino-evo-devo. Acta Nat. 2019;11:65\u201372.","journal-title":"Acta Nat"},{"key":"423_CR3","first-page":"387","volume":"58","author":"AP Kozlov","year":"2012","unstructured":"Kozlov AP, Zabezhinski MA, Popovich IG, Polev DE, Shilov ES, Murashev BV. Hyperplastic skin growth on the head of goldfish\u2014comparative oncology aspects. Probl Oncol (Voprosi Oncologii). 2012;58:387\u201393.","journal-title":"Probl Oncol (Voprosi Oncologii)"},{"key":"423_CR4","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s13027-019-0262-5","volume":"14","author":"EA Matyunina","year":"2019","unstructured":"Matyunina EA, Emelyanov AV, Kurbatova TV, Makashov AA, Mizgirev IV, Kozlov AP. Evolutionarily novel genes are expressed in transgenic fish tumors and their orthologs are involved in the development of progressive traits in humans. Infect Agents Cancer. 2019;14:46.","journal-title":"Infect Agents Cancer"},{"key":"423_CR5","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s13027-021-00412-0","volume":"17","author":"AP Kozlov","year":"2022","unstructured":"Kozlov AP. Mammalian tumor-like organs. 1. The role of tumor-like normal organs and atypical tumor organs in the evolution of development (carcino-evo-devo). Infect Agents Cancer. 2022;17:2.","journal-title":"Infect Agents Cancer"},{"key":"423_CR6","volume-title":"The adipose organ","author":"S Cinti","year":"2001","unstructured":"Cinti S. The adipose organ. Milan: Editrice Kurtis; 2001."},{"key":"423_CR7","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1038\/sj.ijo.0802326","volume":"27","author":"KN Frayn","year":"2003","unstructured":"Frayn KN, Karpe F, Fielding BA, Macdonald IA, Coppack SW. Integrative physiology of human adipose tissue. Int J Obes Relat Metab Disord. 2003;27:875\u201388.","journal-title":"Int J Obes Relat Metab Disord"},{"key":"423_CR8","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.plefa.2005.04.010","volume":"73","author":"S Cinti","year":"2005","unstructured":"Cinti S. The adipose organ. Prostaglandins Leukot Essent Fatty Acids. 2005;73:9\u201315.","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"423_CR9","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/978-1-59745-370-7_1","volume-title":"Adipose tissue and adipokines in health and disease. Nutrition and health","author":"S Cinti","year":"2007","unstructured":"Cinti S. The adipose organ. In: Fantuzzi G, Mazzone T, editors. Adipose tissue and adipokines in health and disease. Nutrition and health. Totowa: Humana Press Inc; 2007. p. 3\u201319."},{"key":"423_CR10","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1242\/dmm.009662","volume":"5","author":"S Cinti","year":"2012","unstructured":"Cinti S. The adipose organ at a glance. Dis Model Mech. 2012;5:588\u201394.","journal-title":"Dis Model Mech"},{"key":"423_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s13105-018-0658-5","volume":"75","author":"A Kaisanlahti","year":"2019","unstructured":"Kaisanlahti A, Glumoff T. Browning of white fat: agents and implications for beige adipose tissue to type 2 diabetes. J Physiol Biochem. 2019;75:1\u201310.","journal-title":"J Physiol Biochem"},{"key":"423_CR12","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1080\/21623945.2017.1367881","volume":"6","author":"MA Horowitz","year":"2017","unstructured":"Horowitz MA, Berry R, Holtrup B, Sebo Z, Nelson T, Fretz JA, et al. Bone marrow adipocytes. Adipocyte. 2017;6:193\u2013204.","journal-title":"Adipocyte"},{"key":"423_CR13","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1038\/nature07182","volume":"454","author":"P Seal","year":"2008","unstructured":"Seal P, Bjork B, Yang W, Kajimura S, Chin S, Kuang S, et al. PRDM16 controls a brown fat\/skeletal muscle switch. Nature. 2008;454:961\u20137.","journal-title":"Nature"},{"key":"423_CR14","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1038\/nature07221","volume":"454","author":"Y-H Tseng","year":"2008","unstructured":"Tseng Y-H, Kokkotou E, Schulz TJ, Huang TL, Winnay JN, Taniguchi CM, et al. New role of bone morphogenetic protein 7 in brown adipogenesis and energy expenditure. Nature. 2008;454:1000\u20134.","journal-title":"Nature"},{"key":"423_CR15","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.ccell.2018.12.002","volume":"35","author":"D Ishay-Ronen","year":"2019","unstructured":"Ishay-Ronen D, Diepenbruck M, Kalathur RKR, Sugiyama N, Tiede S, Ivanek R, et al. Gain fat-lose metastasis: converting invasive breast cancer cells into adipocytes inhibits cancer metastasis. Cancer Cell. 2019;35:17\u201332.","journal-title":"Cancer Cell"},{"key":"423_CR16","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1073\/pnas.0708579105","volume":"105","author":"B Kadereit","year":"2008","unstructured":"Kadereit B, Kumar P, Wang W-J, Miranda D, Snapp EL, Severina N, et al. Evolutionarily conserved gene family important for fat storage. Proc Natl Acad Sci USA. 2008;105:94\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"key":"423_CR17","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.cmet.2017.12.002","volume":"27","author":"RK Zwick","year":"2018","unstructured":"Zwick RK, Guerrero-Juarez CF, Horsley V, Plikus MV. Anatomical, physiological and functional diversity of adipose tissue. Cell Metab. 2018;27:63\u201383.","journal-title":"Cell Metab"},{"key":"423_CR18","first-page":"227","volume-title":"Adipose tissue biology","author":"CM Pond","year":"2011","unstructured":"Pond CM. The evolution of mammalian adipose tissue. In: Symonds M, editor. Adipose tissue biology. New York: Springer; 2011. p. 227\u201369."},{"key":"423_CR19","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.cell.2007.10.004","volume":"131","author":"S Gesta","year":"2007","unstructured":"Gesta S, Tseng Y-H, Kahn CR. Developmental origin of fat: tracking obesity to its source. Cell. 2007;131:242\u201356.","journal-title":"Cell"},{"key":"423_CR20","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/1741-7007-6-17","volume":"6","author":"NV Mezentseva","year":"2008","unstructured":"Mezentseva NV, Kumaratilake JS, Newman SA. The brown adipocyte differentiation pathway in birds: an evolutionary toad not taken. BMC Biol. 2008;6:17.","journal-title":"BMC Biol"},{"key":"423_CR21","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1038\/nature05483","volume":"444","author":"ED Rosen","year":"2006","unstructured":"Rosen ED, Spiegelman BM. Adipocytes as regulators of energy balance and glucose homeostasis. Nature. 2006;444:847\u201353.","journal-title":"Nature"},{"key":"423_CR22","doi-asserted-by":"publisher","first-page":"2094","DOI":"10.1172\/JCI45887","volume":"121","author":"K Sun","year":"2011","unstructured":"Sun K, Kusminski CM, Scherer PE. Adipose tissue remodeling, and obesity. J Clin Investig. 2011;121:2094\u2013101.","journal-title":"J Clin Investig"},{"key":"423_CR23","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1148\/rg.245045120","volume":"24","author":"MD Murphey","year":"2004","unstructured":"Murphey MD, Carrol JF, Flemming DJ, Pope TL, Gannon FH, Kransdorf MJ, et al. From the archives of the AFIP: benign musculoskeletal lipomatous lesions. Radiographics. 2004;24:1433\u201366.","journal-title":"Radiographics"},{"key":"423_CR24","unstructured":"Awh MA. Lipoma and liposarcoma. In: Radsource. MRI Web Clinic. 2014. https:\/\/radsource.us\/lipoma-and-liposarcoma\/. Accessed Jan 2014."},{"key":"423_CR25","doi-asserted-by":"publisher","first-page":"779","DOI":"10.5435\/JAAOS-D-17-00045","volume":"26","author":"CN Johnson","year":"2018","unstructured":"Johnson CN, Ha AS, Chen E, Davidson D. Lipomatous soft-tissue tumors. J Am Acad Orthop Surg. 2018;26:779\u201388.","journal-title":"J Am Acad Orthop Surg"},{"key":"423_CR26","doi-asserted-by":"publisher","first-page":"60","DOI":"10.4161\/org.1.2.1338","volume":"1","author":"JA Davies","year":"2004","unstructured":"Davies JA. Inverse correlation between an organ\u2019s cancer rate and its evolutionary antiquity. Organogenesis. 2004;1:60\u20133.","journal-title":"Organogenesis"},{"key":"423_CR27","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-16483-5_106","volume-title":"Encyclopedia of cancer","author":"F Pedeutour","year":"2011","unstructured":"Pedeutour F, Italiano A. Adipose tumors. In: Schwab M, editor. Encyclopedia of cancer. Berlin: Springer; 2011. https:\/\/doi.org\/10.1007\/978-3-642-16483-5_106."},{"key":"423_CR28","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394\u2013424.","journal-title":"CA Cancer J Clin"},{"key":"423_CR29","doi-asserted-by":"publisher","first-page":"483154","DOI":"10.1155\/2011\/483154","volume":"2011","author":"R Conyers","year":"2011","unstructured":"Conyers R, Young S, Thomas DM. Liposarcoma: molecular genetics and therapeutics. Sarcoma. 2011;2011:483154.","journal-title":"Sarcoma"},{"key":"423_CR30","doi-asserted-by":"publisher","first-page":"635","DOI":"10.12688\/f1000research.24803.1","volume":"9","author":"S Shen","year":"2020","unstructured":"Shen S, Clairambault J. Cell plasticity in cancer cell populations. F1000 Res. 2020;9:635.","journal-title":"F1000 Res"},{"key":"423_CR31","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3389\/fendo.2011.00087","volume":"2","author":"DF Pisani","year":"2011","unstructured":"Pisani DF, Djedani M, Beranger GE, Elabd C, Scheideler M, Ailhaud G, et al. Differentiation of human adipose-derived stem cells into \u201cbrite\u201d (brown-in-white) adipocytes. Front Endocrinol. 2011;2:87.","journal-title":"Front Endocrinol"},{"key":"423_CR32","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3389\/fendo.2012.00035","volume":"3","author":"H Yadav","year":"2012","unstructured":"Yadav H, Rane SG. TGF-\u03b2\/Smad3 signaling regulates brown adipocyte induction in white adipose tissue. Front Endocrinol. 2012;3:35.","journal-title":"Front Endocrinol"},{"key":"423_CR33","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.3390\/cells8121507","volume":"8","author":"E Bielczyk-Maczynska","year":"2019","unstructured":"Bielczyk-Maczynska E. White adipocyte plasticity in physiology and disease. Cells. 2019;8:1507.","journal-title":"Cells"},{"key":"423_CR34","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1038\/s41467-019-09748-z","volume":"10","author":"PA Joshi","year":"2019","unstructured":"Joshi PA, Waterhouse PD, Kasaian K, Fang H, Gulyaeva O, Sul HS, et al. PDGFR\u03b1+ stromal adipocyte progenitors transition into epithelial cells during lobulo-alveologenesis in the murine mammary gland. Nat Commun. 2019;10:1760.","journal-title":"Nat Commun"},{"key":"423_CR35","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.3389\/fonc.2020.01554","volume":"10","author":"V D\u2019Esposito","year":"2020","unstructured":"D\u2019Esposito V, Ambrosio MR, Giuliano M, Cabaro S, Miele C, Beguinot F, et al. Mammary adipose tissue control of breast cancer progression: Impact of obesity and diabetes. Front Oncol. 2020;10:1554.","journal-title":"Front Oncol"},{"key":"423_CR36","doi-asserted-by":"publisher","first-page":"624903","DOI":"10.3389\/fphys.2020.624903","volume":"11","author":"J Herold","year":"2021","unstructured":"Herold J, Kalucka J. Angiogenesis in adipose tissue: the interplay between adipose and endothelial cells. Front Physiol. 2021;11:624903.","journal-title":"Front Physiol"},{"key":"423_CR37","first-page":"720926","volume":"2011","author":"M Itoh","year":"2011","unstructured":"Itoh M, Suganami T, Hachiya R, Ogawa Y. Adipose tissue remodeling as homeostatic inflammation. Int J Inflam. 2011;2011:720926.","journal-title":"Int J Inflam"},{"key":"423_CR38","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.immuni.2019.06.025","volume":"51","author":"FR Greten","year":"2019","unstructured":"Greten FR, Grivennikov SI. Inflammation and cancer: triggers, mechanisms, and consequences. Immunity. 2019;51:27\u201341.","journal-title":"Immunity"},{"key":"423_CR39","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.molonc.2012.09.005","volume":"6","author":"SS Nair","year":"2012","unstructured":"Nair SS, Kumar R. Chromatin remodeling in cancer: a gateway to regulate gene transcription. Mol Oncol. 2012;6:611\u20139.","journal-title":"Mol Oncol"},{"key":"423_CR40","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1242\/dmm.004077","volume":"4","author":"TR Cox","year":"2011","unstructured":"Cox TR, Erler JT. Remodeling and homeostasis of the extracellular matrix: implications for fibrotic diseases and cancer. Dis Models Mech. 2011;4:165\u201378.","journal-title":"Dis Models Mech"},{"key":"423_CR41","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.semcancer.2019.09.004","volume":"62","author":"V Mohan","year":"2019","unstructured":"Mohan V, Das A, Sagi I. Emerging roles of ECM remodeling processes in cancer. Semin Cancer Biol. 2019;62:192\u2013200.","journal-title":"Semin Cancer Biol"},{"key":"423_CR42","doi-asserted-by":"publisher","first-page":"3496","DOI":"10.1038\/onc.2013.304","volume":"33","author":"RH Farnsworth","year":"2014","unstructured":"Farnsworth RH, Lackmann M, Achen MG, Stacker SA. Vascular remodeling in cancer. Oncogene. 2014;33:3496\u2013505.","journal-title":"Oncogene"},{"key":"423_CR43","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.7150\/jca.31406","volume":"11","author":"L Chang","year":"2020","unstructured":"Chang L, Fang S, Gu W. The molecular mechanism of metabolic remodeling in lung cancer. J Cancer. 2020;11:1403\u201311.","journal-title":"J Cancer"},{"key":"423_CR44","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1172\/JCI88883","volume":"127","author":"C Crewe","year":"2017","unstructured":"Crewe C, An YA, Scherer PE. The ominous triad of adipose tissue dysfunction: inflammation, fibrosis, and impaired angiogenesis. J Clin Investig. 2017;127:74\u201382.","journal-title":"J Clin Investig"},{"key":"423_CR45","doi-asserted-by":"publisher","first-page":"2358","DOI":"10.3390\/ijms20092358","volume":"20","author":"M Longo","year":"2019","unstructured":"Longo M, Zatterale F, Naderi J, Parrillo L, Formisano P, Raciti GA, et al. Adipose tissue disfunction as the determinant of obesity-associated metabolic complications. Int J Mol Sci. 2019;20:2358.","journal-title":"Int J Mol Sci"},{"key":"423_CR46","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.3390\/ijms20051146","volume":"20","author":"M Wlodarczyk","year":"2019","unstructured":"Wlodarczyk M, Nowika G. Obesity, DNA damage, and development of obesity-related diseases. Int J Mol Sci. 2019;20:1146.","journal-title":"Int J Mol Sci"},{"key":"423_CR47","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/978-3-319-07320-0_2","volume":"824","author":"C Cerda","year":"2014","unstructured":"Cerda C, Sanchez C, Climent B, V\u00e1zquez A, Iradi A, El Amrani F, et al. Oxidative stress and DNA damage in obesity-related tumorigenesis. Adv Exp Med Biol. 2014;824:5\u201317.","journal-title":"Adv Exp Med Biol"},{"key":"423_CR48","doi-asserted-by":"publisher","first-page":"3062","DOI":"10.2337\/db16-0014","volume":"65","author":"B Vergoni","year":"2016","unstructured":"Vergoni B, Cornejo PJ, Gilleron J, Djedaini M, Ceppo F, Jacquel A, et al. DNA damage and the activation of the p53 pathway mediate alterations in metabolic and secretory functions of adipocytes. Diabetes. 2016;65:3062\u201374.","journal-title":"Diabetes"},{"key":"423_CR49","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1177\/1535370219826031","volume":"244","author":"JJ Moon","year":"2019","unstructured":"Moon JJ, Lu A, Moon C. Role of genomic instability in human carcinogenesis. Exp Biol Med (Maywood). 2019;244:227\u201340.","journal-title":"Exp Biol Med (Maywood)"},{"key":"423_CR50","doi-asserted-by":"publisher","first-page":"2621","DOI":"10.3390\/cells9122621","volume":"9","author":"YK Lee","year":"2020","unstructured":"Lee YK, Chung YS, Lee JH, Chun JM, Park JH. The intricate role of p53 in adipocyte differentiation and function. Cells. 2020;9:2621.","journal-title":"Cells"},{"key":"423_CR51","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1038\/nrm2858","volume":"11","author":"S Negrini","year":"2010","unstructured":"Negrini S, Gorgoulis VG, Halazonetis TD. Genomic instability\u2014an evolving hallmark of cancer. Nature Rev Mol Cell Biol. 2010;11:220\u20138.","journal-title":"Nature Rev Mol Cell Biol"},{"key":"423_CR52","doi-asserted-by":"publisher","first-page":"238","DOI":"10.3390\/cells8030238","volume":"8","author":"M Slayton","year":"2019","unstructured":"Slayton M, Gupta A, Balakrishnan B, Puri V. CIDE proteins in human health and disease. Cells. 2019;8:238.","journal-title":"Cells"},{"key":"423_CR53","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1111\/tra.12717","volume":"21","author":"F-J Chen","year":"2020","unstructured":"Chen F-J, Yin Y, Chua BT, Li P. CIDE family proteins control lipid homeostasis and the development of metabolic diseases. Traffic. 2020;21:94\u2013105.","journal-title":"Traffic"},{"key":"423_CR54","doi-asserted-by":"publisher","first-page":"5455","DOI":"10.1038\/s41467-020-19229-3","volume":"11","author":"L Wang","year":"2020","unstructured":"Wang L, Wang SP, Shi Y, Li R, Gunter S, Ong YT, et al. YAP and TAZ protect against white adipocyte cell death during obesity. Nat Commun. 2020;11:5455.","journal-title":"Nat Commun"},{"key":"423_CR55","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1038\/s41366-020-0630-7","volume":"45","author":"AG Izquierdo","year":"2021","unstructured":"Izquierdo AG, Carreira MC, Rodrigez-Carnero G, Fernandez-Quintela A, Sueiro AM, Martinez-Olmos MA, et al. Weight loss normalizes enhanced expression of the oncogene survivin in visceral adipose tissue and blood leukocytes from individuals with obesity. Int J Obes. 2021;45:206\u201316.","journal-title":"Int J Obes"},{"key":"423_CR56","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1515\/hmbci-2015-0073","volume":"26","author":"A Booth","year":"2016","unstructured":"Booth A, Magnuson A, Fouts J, Foster MT. Adipose tissue: an endocrine organ playing a role in metabolic regulation. Horm Mol Biol Clin Investig. 2016;26:25\u201342.","journal-title":"Horm Mol Biol Clin Investig"},{"key":"423_CR57","doi-asserted-by":"publisher","first-page":"65","DOI":"10.3389\/fendo.2019.00065","volume":"10","author":"JMP Holly","year":"2019","unstructured":"Holly JMP, Biernacka K, Perks CM. Systemic metabolism, its regulators, and cancer: past mistakes and future potential. Front Endocrinol (Lausanne). 2019;10:65.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"423_CR58","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1159\/000224751","volume":"27","author":"E Ertl","year":"1973","unstructured":"Ertl E. \u2018Systemic effects\u2019 during the growth of malignant experimental tumors. Oncology. 1973;27:415\u201329.","journal-title":"Oncology"},{"key":"423_CR59","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1038\/ncb3015","volume":"16","author":"SS McAllister","year":"2014","unstructured":"McAllister SS, Weinberg RA. The tumor-induced systemic environment as a critical regulator of cancer progression and metastasis. Nat Cell Biol. 2014;16:717\u201327.","journal-title":"Nat Cell Biol"},{"key":"423_CR60","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1085\/jgp.8.6.519","volume":"8","author":"O Warburg","year":"1927","unstructured":"Warburg O, Wind F, Negelein E. The metabolism of tumors in the body. J Gen Physiol. 1927;8:519\u201330.","journal-title":"J Gen Physiol"},{"key":"423_CR61","doi-asserted-by":"publisher","first-page":"38908","DOI":"10.18632\/oncotarget.7676","volume":"7","author":"L Yu","year":"2016","unstructured":"Yu L, Chen X, Wang L, Chen S. The sweet trap in tumors: aerobic glycolysis and potential targets for therapy. Oncotarget. 2016;7:38908\u201326.","journal-title":"Oncotarget"},{"key":"423_CR62","doi-asserted-by":"publisher","first-page":"317","DOI":"10.3389\/fonc.2020.00317","volume":"10","author":"X Lin","year":"2020","unstructured":"Lin X, Xiao Z, Chen T, Liang SH, Guo H. Glucose metabolism on tumor plasticity, diagnosis, and treatment. Front Oncol. 2020;10:317.","journal-title":"Front Oncol"},{"key":"423_CR63","doi-asserted-by":"publisher","first-page":"751","DOI":"10.2337\/diabetes.54.3.751","volume":"54","author":"P Cettour-Rose","year":"2005","unstructured":"Cettour-Rose P, Samec S, Russel AP, Summermatter S, Mainieri D, Carrillo-Theander C, et al. Redistribution of glucose from skeletal muscle to adipose tissue during catch-up fat. Diabetes. 2005;54:751\u20136.","journal-title":"Diabetes"},{"key":"423_CR64","doi-asserted-by":"publisher","first-page":"2228","DOI":"10.2337\/db08-1793","volume":"58","author":"S Summermatter","year":"2009","unstructured":"Summermatter S, Marcelino H, Arsenijevic D, Buchala A, Aprikian O, Assimacopoulos-Jeannet F, et al. Adipose tissue plasticity during catch-up fat driven thrifty metabolism: relevance for muscle-adipose glucose redistribution during catch-up growth. Diabetes. 2009;58:2228\u201337.","journal-title":"Diabetes"},{"key":"423_CR65","doi-asserted-by":"publisher","first-page":"362","DOI":"10.2337\/db12-0255","volume":"62","author":"H Marcelino","year":"2013","unstructured":"Marcelino H, Veyrat-Durebex C, Summermater S, Sarafian D, Miles-Chan J, Arsenijevic D, et al. A role for adipose tissue de novo lipogenesis in glucose homeostasis during catch-up growth. Diabetes. 2013;62:362\u201372.","journal-title":"Diabetes"},{"key":"423_CR66","first-page":"251","volume-title":"Clinics in oncology","author":"WD DeWys","year":"1986","unstructured":"DeWys WD. Weight loss and nutritional abnormalities in cancer patients: incidence, severity, and significance. In: Calman KC, Fearon KCH, editors. Clinics in oncology. London: Saunders; 1986. p. 251\u201361."},{"key":"423_CR67","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1093\/ajcn\/83.6.1345","volume":"83","author":"KC Fearon","year":"2006","unstructured":"Fearon KC, Voss AC, Hustead DS, Cancer Cachexia Study Group. Definition of cancer cachexia: effect of weight loss, reduced food intake, and systemic inflammation on functional status and prognosis. Am J Clin Nutr. 2006;83:1345\u201350.","journal-title":"Am J Clin Nutr"},{"key":"423_CR68","doi-asserted-by":"publisher","first-page":"257","DOI":"10.4103\/0973-029X.86670","volume":"15","author":"R Dhanapal","year":"2011","unstructured":"Dhanapal R, Saraswathi T, Govind RN. Cancer cachexia. J Oral Maxillofac Pathol. 2011;15:257\u201360.","journal-title":"J Oral Maxillofac Pathol"},{"key":"423_CR69","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/nature13528","volume":"513","author":"S Kir","year":"2014","unstructured":"Kir S, White JP, Kleiner S, Kazak L, Cohen P, Baracos VE, et al. Tumor-derived PTHrP triggers adipose tissue browning and cancer cachexia. Nature. 2014;513:100\u20134.","journal-title":"Nature"},{"issue":"Suppl 5","key":"423_CR70","doi-asserted-by":"publisher","first-page":"242S","DOI":"10.1038\/oby.2006.317","volume":"14","author":"ES Ahima","year":"2006","unstructured":"Ahima ES. Adipose tissue as an endocrine organ. Obesity (Silver Spring). 2006;14(Suppl 5):242S-249S.","journal-title":"Obesity (Silver Spring)"},{"key":"423_CR71","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.mce.2009.08.018","volume":"316","author":"S Galic","year":"2010","unstructured":"Galic S, Oakhill JS, Steinberg GR. Adipose tissue as an endocrine organ. Mol Cell Endocrinol. 2010;316:129\u201339.","journal-title":"Mol Cell Endocrinol"},{"key":"423_CR72","doi-asserted-by":"publisher","first-page":"560","DOI":"10.3390\/ijms22115560","volume":"22","author":"A Alvarez-Artime","year":"2021","unstructured":"Alvarez-Artime A, Garcia-Soler B, Sainz RM, Mayo JC. Emerging roles for browning of white adipose tissue in prostate cancer malignant behavior. Int J Mol Sci. 2021;22:560.","journal-title":"Int J Mol Sci"},{"key":"423_CR73","doi-asserted-by":"publisher","first-page":"640","DOI":"10.3389\/fphys.2018.00640","volume":"9","author":"V Francisco","year":"2018","unstructured":"Francisco V, Pino J, Campos-Cabaleiro V, Ruiz-Fernandez C, Mera A, Gonzalez-Gay MA, et al. Obesity, fat mass and immune system: role for leptin. Front Physiol. 2018;9:640.","journal-title":"Front Physiol"},{"key":"423_CR74","first-page":"55","volume":"65","author":"AM Neville","year":"1972","unstructured":"Neville AM. Ectopic production of hormones by tumours. Pathological aspects of the para-endocrine syndrome. Proc R Soc Med. 1972;65:55\u20139.","journal-title":"Proc R Soc Med"},{"key":"423_CR75","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1136\/jcp.s1-7.1.26","volume":"7","author":"TJ Martin","year":"1976","unstructured":"Martin TJ. Secretion of hypothalamic and pituitary hormones by non-endocrine tumours. J Clin Pathol Suppl (Assoc Clin Pathol). 1976;7:26\u201330.","journal-title":"J Clin Pathol Suppl (Assoc Clin Pathol)"},{"key":"423_CR76","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1210\/edrv-1-1-45","volume":"1","author":"SB Baylin","year":"1980","unstructured":"Baylin SB, Mendelsohn G. Ectopic (inappropriate) hormone production by tumors: mechanisms involved and the biological and clinical implications. Endocr Rev. 1980;1:45\u201377.","journal-title":"Endocr Rev"},{"key":"423_CR77","volume-title":"Holland-frei cancer medicine","author":"SCJ Yeung","year":"2003","unstructured":"Yeung SCJ, Gagel RF, et al. Endocrine paraneoplastic syndromes (\u201cectopic\u201d hormone production). In: Kufe DW, Pollock RE, Weichselbaum RR, Bast RC, Gansler TS, Holland JF, et al., editors. Holland-frei cancer medicine. 6th ed. Hamilton: BC Decker; 2003.","edition":"6"},{"key":"423_CR78","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1038\/nature21365","volume":"542","author":"T Thomou","year":"2017","unstructured":"Thomou T, Mori MA, Dreyfuss JM, Konishi M, Sakaguchi M, Wolfrum C, et al. Adipose-derived circulating miRNAs regulate gene expression in other tissues. Nature. 2017;542:450\u20135.","journal-title":"Nature"},{"key":"423_CR79","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s13045-020-00848-8","volume":"13","author":"M Yi","year":"2020","unstructured":"Yi M, Xu L, Jiao Y, Luo S, Li A, Wu K. The role of cancer-derived microRNAs in cancer immune escape. J Hematol Oncol. 2020;13:25.","journal-title":"J Hematol Oncol"},{"key":"423_CR80","doi-asserted-by":"publisher","first-page":"66","DOI":"10.3945\/an.115.010207","volume":"7","author":"CJ Andersen","year":"2016","unstructured":"Andersen CJ, Murphy KE, Fernandez ML. Impact of obesity and metabolic syndrome on immunity. Adv Nutr. 2016;7:66\u201375.","journal-title":"Adv Nutr"},{"key":"423_CR81","doi-asserted-by":"publisher","DOI":"10.1515\/hmbci-2018-0083","author":"CM Solt","year":"2019","unstructured":"Solt CM, Hill JL, Vonderpool K, Foster MT. Obesity-induced immune dysfunction and immunosuppression: TEM observation of visceral and subcutaneous lymph node microarchitecture and immune cell interactions. Horm Mol Biol Clin Investig. 2019. https:\/\/doi.org\/10.1515\/hmbci-2018-0083.","journal-title":"Horm Mol Biol Clin Investig"},{"key":"423_CR82","doi-asserted-by":"publisher","first-page":"5527","DOI":"10.1158\/0008-5472.CAN-05-4128","volume":"66","author":"R Kim","year":"2006","unstructured":"Kim R, Emi M, Tanabe K, Arihiro K. Tumor-driven evolution of immunosuppressive networks during malignant progression. Cancer Res. 2006;66:5527\u201336.","journal-title":"Cancer Res"},{"key":"423_CR83","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1111\/j.1365-2567.2006.02430.x","volume":"119","author":"R Kim","year":"2006","unstructured":"Kim R, Emi M, Tanabe K. Cancer immunosuppression and autoimmune disease: beyond immunosuppressive networks for tumor immunity. Immunology. 2006;119:254\u201364.","journal-title":"Immunology"},{"key":"423_CR84","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/s12943-019-1047-6","volume":"18","author":"C Lu","year":"2019","unstructured":"Lu C, Rong D, Zhang B, Zheng W, Wang X, Chen Z. Current perspective on the immunosuppressive tumor microenvironment in hepatocellular carcinoma: challenges and opportunities. Mol Cancer. 2019;18:130.","journal-title":"Mol Cancer"},{"key":"423_CR85","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/s41571-019-0175-7","volume":"16","author":"Y Togashi","year":"2019","unstructured":"Togashi Y, Shitara K, Nishikawa H. Regulatory T cells in cancer immunosuppression\u2014implications for anticancer therapy. Nat Rev Clin Oncol. 2019;16:356\u201371.","journal-title":"Nat Rev Clin Oncol"},{"key":"423_CR86","doi-asserted-by":"publisher","first-page":"1848","DOI":"10.1016\/j.cell.2020.11.009","volume":"183","author":"AE Ringel","year":"2020","unstructured":"Ringel AE, Drijvers JM, Baker GJ, Catozzi A, Garcia-Canaveras JC, Gassaway BM, et al. Obesity shapes metabolism in the tumor microenvironment to suppress antitumor immunity. Cell. 2020;183:1848\u201366.","journal-title":"Cell"},{"key":"423_CR87","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1097\/MOL.0b013e328321b3a8","volume":"20","author":"J Szendroedi","year":"2009","unstructured":"Szendroedi J, Roden M. Ectopic lipids and organ function. Curr Opin Lipidol. 2009;20:50\u20136.","journal-title":"Curr Opin Lipidol"},{"key":"423_CR88","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/S2213-8587(14)70065-8","volume":"2","author":"AP de Vries","year":"2014","unstructured":"de Vries AP, Ruggenenti P, Ruan XZ, Praga M, Cruzado JM, Bajema IM, et al. Fatty kidney: emerging role of ectopic lipid in obesity-related renal disease. Lancet Diabetes Endocrinol. 2014;2:417\u201326.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"423_CR89","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1056\/NEJMra1011035","volume":"371","author":"GI Shulman","year":"2014","unstructured":"Shulman GI. Ectopic fat in insulin resistance, dyslipidemia, and cardiometabolic disease. N Engl J Med. 2014;371:1131\u201341.","journal-title":"N Engl J Med"},{"key":"423_CR90","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1038\/oby.2007.110","volume":"16","author":"KE Pinnick","year":"2008","unstructured":"Pinnick KE, Collins SC, Londos C, Gauguier D, Clark A, Fielding BA. Pancreatic ectopic fat is characterized by adipocyte infiltration and altered lipid composition. Obesity. 2008;16:522\u201330.","journal-title":"Obesity"},{"key":"423_CR91","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1055\/s-0033-1358669","volume":"45","author":"B Gaborit","year":"2013","unstructured":"Gaborit B, Abdesselam I, Dutour A. Epicardial fat: More than just an \u201cEpi\u201d phenomenon? Horm Metab Res. 2013;45:991\u20131001.","journal-title":"Horm Metab Res"},{"key":"423_CR92","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3389\/fendo.2016.00069","volume":"7","author":"MW Hamrick","year":"2016","unstructured":"Hamrick MW, McGee-Lawrence ME, Frechette DM. Fatty infiltration of skeletal muscle: mechanisms and comparisons with bone marrow adiposity. Front Endocrinol. 2016;7:69.","journal-title":"Front Endocrinol"},{"key":"423_CR93","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.celrep.2019.03.038","volume":"27","author":"A Girousse","year":"2019","unstructured":"Girousse A, Gil-Ortega M, Bourlier V, Bergeaud C, Sastourn\u00e9-Arrey Q, Moro C, et al. The release of adipose stromal cells from subcutaneous adipose tissue regulates intramuscular adipocyte deposition. Cell Rep. 2019;27:323\u201333.","journal-title":"Cell Rep"},{"key":"423_CR94","doi-asserted-by":"publisher","first-page":"2927","DOI":"10.1158\/1078-0432.CCR-09-2329","volume":"16","author":"BA Teicher","year":"2010","unstructured":"Teicher BA, Fricker SP. CXCL12\/CXCR4 pathway in cancer. Clin Cancer Res. 2010;16:2927\u201331.","journal-title":"Clin Cancer Res"},{"key":"423_CR95","first-page":"801","volume":"16","author":"Y Zhou","year":"2018","unstructured":"Zhou Y, Cao H-B, Li W-J, Zhao L. The CXCL12 (SDF-1)\/CXCR4 chemokine axis: oncogenic properties, molecular targeting, and synthetic and natural product CXCR4 inhibitors for cancer therapy. Clin J Nat Med. 2018;16:801\u201310.","journal-title":"Clin J Nat Med"},{"key":"423_CR96","doi-asserted-by":"publisher","first-page":"3026","DOI":"10.2174\/0929867324666170830111531","volume":"26","author":"W Zhou","year":"2019","unstructured":"Zhou W, Guo S, Liu M, Barrow ME, Wang G. Targeting CXCL12\/CXCR4 axis in tumor immunotherapy. Curr Med Chem. 2019;26:3026\u201341.","journal-title":"Curr Med Chem"},{"key":"423_CR97","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1159\/000225596","volume":"39","author":"VM Dilman","year":"1982","unstructured":"Dilman VM, Berstein LM, Ostroumova MN, Fedorov SN, Poroshina TE, Tsyrlina EV, et al. Metabolic immunosuppression and metabolic immunotherapy. Oncology. 1982;39:13\u20139.","journal-title":"Oncology"},{"key":"423_CR98","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.critrevonc.2013.01.005","volume":"87","author":"VN Anisimov","year":"2013","unstructured":"Anisimov VN, Bartke A. The key role of growth hormone-insulin-IGF-1 signaling in aging and cancer. Crit Rev Oncol Hematol. 2013;87:201\u201323.","journal-title":"Crit Rev Oncol Hematol"},{"key":"423_CR99","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1039\/9781782626602-00416","volume-title":"RSC drug discovery series no. 57: anti-aging drugs: from basic research to clinical practice","author":"VN Anisimov","year":"2017","unstructured":"Anisimov VN. Antidiabetic biguanides as anti-aging drugs. In: Vaiserman AM, editor. RSC drug discovery series no. 57: anti-aging drugs: from basic research to clinical practice. Cambridge: Royal Society of Chemistry; 2017. p. 416\u201331."},{"key":"423_CR100","doi-asserted-by":"publisher","first-page":"F27","DOI":"10.1530\/ERC-11-0374","volume":"19","author":"DH Cohen","year":"2012","unstructured":"Cohen DH, LeRoith D. Obesity, type 2 diabetes, and cancer: the insulin and IGF connection. Endocr Relat Cancer. 2012;19:F27\u201345.","journal-title":"Endocr Relat Cancer"},{"key":"423_CR101","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1038\/nrc1387","volume":"4","author":"MN Pollak","year":"2004","unstructured":"Pollak MN, Schernhammer ES, Hankinson SE. Insulin-like growth factors and neoplasia. Nat Rev Cancer. 2004;4:505\u201318.","journal-title":"Nat Rev Cancer"},{"key":"423_CR102","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/S0140-6736(00)49915-0","volume":"133","author":"S Paget","year":"1889","unstructured":"Paget S. The distribution of secondary growths in cancer of the breast. Lancet. 1889;133:571\u20133.","journal-title":"Lancet"},{"key":"423_CR103","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1007\/s11912-016-0539-4","volume":"18","author":"H Lennon","year":"2016","unstructured":"Lennon H, Sperrin M, Badrick E, Renehan AG. The obesity paradox in cancer: a review. Curr Oncol Rep. 2016;18:56.","journal-title":"Curr Oncol Rep"},{"key":"423_CR104","doi-asserted-by":"publisher","first-page":"596","DOI":"10.3389\/fonc.2019.00596","volume":"9","author":"F Sanchez-Jimenez","year":"2019","unstructured":"Sanchez-Jimenez F, Perez-Perez A, de la Cruz-Merino L, Sanchez-Margalet V. Obesity and breast cancer: role of leptin. Front Oncol. 2019;9:596.","journal-title":"Front Oncol"},{"key":"423_CR105","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144:646\u201374.","journal-title":"Cell"},{"key":"423_CR106","doi-asserted-by":"publisher","first-page":"372","DOI":"10.3390\/cells8040372","volume":"8","author":"J Wang","year":"2019","unstructured":"Wang J, Ge J, Cao H, Zhang X, Guo Y, Li X, et al. Leptin promotes white adipocyte browning by inhibiting the Hh signaling pathway. Cells. 2019;8:372.","journal-title":"Cells"},{"key":"423_CR107","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3389\/fendo.2017.00063","volume":"8","author":"CA Deck","year":"2017","unstructured":"Deck CA, Honeycutt JL, Cheung E, Reynolds HM, Borski RJ. Assessing the functional role of leptin in energy homeostasis and the stress response in vertebrates. Front Endocrinol. 2017;8:63.","journal-title":"Front Endocrinol"},{"key":"423_CR108","doi-asserted-by":"publisher","first-page":"58","DOI":"10.3389\/fendo.2017.00058","volume":"8","author":"RL Londraville","year":"2017","unstructured":"Londraville RL, Prokop JW, Duff RJ, Liu Q, Tuttle M. On the molecular evolution of leptin, leptin receptor, and endospanin. Front Endocrinol. 2017;8:58.","journal-title":"Front Endocrinol"},{"key":"423_CR109","doi-asserted-by":"publisher","first-page":"E552","DOI":"10.1152\/ajpendo.00462.2017","volume":"315","author":"JD Deem","year":"2018","unstructured":"Deem JD, Muta K, Ogimoto K, Nelson JT, Velasco KR, Kaiyala KJ, et al. Leptin regulation of the core body temperature involves mechanisms independent of the thyroid axis. Am J Physiol Endocrinol Metab. 2018;315:E552\u201364.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"423_CR110","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1210\/endrev\/bnz016","volume":"41","author":"AW Fisher","year":"2020","unstructured":"Fisher AW, Cannon B, Negergaard J. Leptin: Is it thermogenic? Endocrine Rev. 2020;41:232\u201360.","journal-title":"Endocrine Rev"},{"key":"423_CR111","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1038\/nm.3615","volume":"20","author":"P Bi","year":"2014","unstructured":"Bi P, Shan T, Liu W, Yue F, Yang X, Liang X-R, et al. Inhibition of Notch signaling promotes browning of white adipose tissue and ameliorates obesity. Nat Med. 2014;20:911\u20138.","journal-title":"Nat Med"},{"key":"423_CR112","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1002\/jcp.25697","volume":"232","author":"T Shan","year":"2017","unstructured":"Shan T, Liu J, Wu W, Xu Z, Wang Y. Roles of Notch signaling in adipocyte progenitor cells and mature adipocytes. J Cel Physiol. 2017;232:1258\u201361.","journal-title":"J Cel Physiol"},{"key":"423_CR113","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/s41419-019-1657-3","volume":"10","author":"M Mandl","year":"2019","unstructured":"Mandl M, Wagner SA, Hartzman FM, Mitterberger-Vogt MC, Zwierzina ME, Mattesich M, et al. Sprouty1 is a weight-loss target gene in human adipose stem-progenitor cells that is mandatory for the initiation of adipogenesis. Cell Death Dis. 2019;10:411.","journal-title":"Cell Death Dis"},{"key":"423_CR114","doi-asserted-by":"publisher","first-page":"2308","DOI":"10.1093\/gerona\/glaa098","volume":"75","author":"M Mandl","year":"2020","unstructured":"Mandl M, Wagner SA, Hartzmann FM, Ejas A, Ritthammer H, Baumgarten S, et al. Sprouty 1 prevents cellular senescence maintaining proliferation and differentiation capacity of human adipose stem\/progenitor cells. J Gerontol A Biol Sci Med Sci. 2020;75:2308\u201319.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"423_CR115","doi-asserted-by":"publisher","first-page":"3264","DOI":"10.1096\/fj.10-155127","volume":"24","author":"S Urs","year":"2010","unstructured":"Urs S, Venkatesh D, Tang Y, Henderson T, Yang X, Friesel RE, et al. Sprouty1 is a critical regulatory switch of mesenchymal stem cell lineage allocation. FASEB J. 2010;24:3264\u201373.","journal-title":"FASEB J"},{"key":"423_CR116","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1042\/BCJ20190599","volume":"477","author":"D Yi","year":"2020","unstructured":"Yi D, Nguen HP, Sul HS. Epigenetic dynamics of the thermogenic gene program of adipocytes. Biochem J. 2020;477:1137\u201348.","journal-title":"Biochem J"},{"key":"423_CR117","doi-asserted-by":"publisher","first-page":"624112","DOI":"10.3389\/fendo.2021.624112","volume":"12","author":"M Hernandez-Quiles","year":"2021","unstructured":"Hernandez-Quiles M, Broekema MF, Kalkhoven E. PPARgamma in metabolism, immunity, and cancer: unified and diverse mechanisms of action. Front Endocrinol (Lausanne). 2021;12:624112.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"423_CR118","doi-asserted-by":"publisher","first-page":"2124","DOI":"10.3390\/ijms19072124","volume":"19","author":"P Corrales","year":"2018","unstructured":"Corrales P, Vidal-Puig A, Medina-Gomez G. PPARs and metabolic disorders associated with challenged adipose tissue plasticity. Int J Mol Sci. 2018;19:2124.","journal-title":"Int J Mol Sci"},{"key":"423_CR119","doi-asserted-by":"publisher","first-page":"8859017","DOI":"10.1155\/2020\/8859017","volume":"2020","author":"OI Rudko","year":"2020","unstructured":"Rudko OI, Tretiakov AV, Naumova EA, Klimov EA. Role of PPARs in progression to anxiety: literature analysis and signaling pathways reconstruction. PPAR Res. 2020;2020:8859017.","journal-title":"PPAR Res"},{"key":"423_CR120","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.1210\/me.2007-0454","volume":"22","author":"KW Park","year":"2008","unstructured":"Park KW, Waki H, Villanueva CJ, Monticelli LA, Hong C, Kang S, et al. Inhibitor of DNA binding 2 is a small molecule-inducible modulator of peroxisome proliferator-activated receptor-expression and adipocyte differentiation. Mol Endocrinol. 2008;22:2038\u201348.","journal-title":"Mol Endocrinol"},{"key":"423_CR121","doi-asserted-by":"publisher","first-page":"E72","DOI":"10.1152\/ajpendo.00284.2016","volume":"312","author":"AW Fisher","year":"2017","unstructured":"Fisher AW, Shabalina IG, Mattsson CL, Abreu-Vieira G, Cannon B, Nedergaard J, et al. UCP1 inhibition in Cidea-overexpressing mice is physiologically counteracted by brown adipocyte tissue hyperrecruitment. Am J Physiol Endocrinol Metab. 2017;312:E72\u201387.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"423_CR122","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.isci.2019.09.011","volume":"20","author":"S Jash","year":"2019","unstructured":"Jash S, Banerjee S, Lee M-J, Farmer SR, Puri V. CIDEA transcriptionally regulates UCP1 for britening and thermogenesis in human fat cells. iScience. 2019;20:73\u201389.","journal-title":"iScience"},{"key":"423_CR123","doi-asserted-by":"publisher","first-page":"2870","DOI":"10.3390\/ijms22062870","volume":"22","author":"T-C Lin","year":"2021","unstructured":"Lin T-C, Hsiao M. Leptin and cancer: updates functional roles in carcinogenesis, therapeutic niches, and developments. Int J Mol Sci. 2021;22:2870.","journal-title":"Int J Mol Sci"},{"key":"423_CR124","doi-asserted-by":"publisher","first-page":"2451","DOI":"10.1182\/blood-2013-08-355818","volume":"123","author":"C Lobry","year":"2014","unstructured":"Lobry C, Oh P, Mansour MR, Look AT, Aifantis I. Notch signaling: Switching an oncogene to a tumor suppressor. Blood. 2014;123:2451\u20139.","journal-title":"Blood"},{"key":"423_CR125","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s10353-017-0491-z","volume":"49","author":"M Brzozowa-Zasada","year":"2017","unstructured":"Brzozowa-Zasada M, Piecuch A, Michlsky M, Segiet O, Kurek J, Harabin-Slowinska M, et al. Notch and its oncogene activity in human malignancies. Eur Surg. 2017;49:199\u2013209.","journal-title":"Eur Surg"},{"key":"423_CR126","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.canlet.2005.12.032","volume":"242","author":"TL Lo","year":"2006","unstructured":"Lo TL, Fong CW, Yusoff P, Mckie AB, Chua MS, Leung HY, et al. Sprouty and cancer: the first term report. Cancer Lett. 2006;242:141\u201350.","journal-title":"Cancer Lett"},{"key":"423_CR127","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1124\/mol.109.055848","volume":"76","author":"F Edwin","year":"2009","unstructured":"Edwin F, Anderson K, Ying C, Patel TB. Intermolecular interactions of Sprouty proteins and their implications in development and disease. Mol Pharmacol. 2009;76:679\u201391.","journal-title":"Mol Pharmacol"},{"key":"423_CR128","doi-asserted-by":"publisher","first-page":"23216","DOI":"10.1038\/srep23216","volume":"6","author":"Q He","year":"2016","unstructured":"He Q, Jing H, Liaw L, Gower L, Vary C, Hua S, et al. Suppression of SPRY1 inhibits triple-negative breast cancer malignancy by decreasing EGF\/EGFR mediated mesenchymal phenotype. Sci Rep. 2016;6:23216.","journal-title":"Sci Rep"},{"key":"423_CR129","doi-asserted-by":"publisher","first-page":"972","DOI":"10.3390\/jcm8070972","volume":"8","author":"V Rosso","year":"2019","unstructured":"Rosso V, Panuzzo C, Petiti J, Carturan S, Dragani M, Andreani G, et al. Reduced expression of Sprouty1 contributes to the aberrant proliferation and impaired apoptosis of acute myeloid leukemia cells. J Clin Med. 2019;8:972.","journal-title":"J Clin Med"},{"key":"423_CR130","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1038\/s41419-020-2585-y","volume":"11","author":"B Montico","year":"2020","unstructured":"Montico B, Collizzi F, Girato G, Rizzo A, Salvati A, Baboci L, et al. Loss of Spry1 reduces the growth of BRAFV600-mutant cutaneous melanoma and improves response to targeted therapy. Cell Death Dis. 2020;11:392.","journal-title":"Cell Death Dis"},{"key":"423_CR131","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.jds.2020.07.013","volume":"16","author":"Y-Y Wang","year":"2021","unstructured":"Wang Y-Y, Wang W-C, Su C-W, Hsu CW, Yuan SS, Chen YK. Overexpression of Sprouty1 protein in human oral squamous cell carcinogenesis. J Dent Sci. 2021;16:21\u20138.","journal-title":"J Dent Sci"},{"key":"423_CR132","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/nrc3638","volume":"14","author":"A Lasorella","year":"2014","unstructured":"Lasorella A, Benezra R, Iavarone A. The ID proteins: master regulators of cancer stem cells and tumour aggressiveness. Nat Rev Cancer. 2014;14:77\u201391.","journal-title":"Nat Rev Cancer"},{"key":"423_CR133","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1038\/mt.2014.83","volume":"22","author":"R Nair","year":"2014","unstructured":"Nair R, Teo WS, Mittal V, Swarbrick A. ID proteins regulate diverse aspects of cancer progression and provide novel therapeutic opportunities. Mol Ther. 2014;22:1407\u201315.","journal-title":"Mol Ther"},{"key":"423_CR134","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s12964-016-0161-y","volume":"15","author":"C Roschger","year":"2017","unstructured":"Roschger C, Cabrele C. The Id-protein family in developmental and cancer-associated pathways. Cell Commun Signal. 2017;15:7.","journal-title":"Cell Commun Signal"},{"issue":"30","key":"423_CR135","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.ccell.2016.05.019","volume":"11","author":"M Ghisi","year":"2016","unstructured":"Ghisi M, Kats L, Masson F, Li J, Kratina T, Vidacs E, et al. Id2 and E proteins orchestrate the initiation and maintenance of MLL-rearranged acute myeloid leukemia. Cancer Cell. 2016;11(30):59\u201374.","journal-title":"Cancer Cell"},{"key":"423_CR136","doi-asserted-by":"publisher","first-page":"3136","DOI":"10.4049\/jimmunol.1601935","volume":"198","author":"J Li","year":"2017","unstructured":"Li J, Roy S, Kim YM, Li S, Zhang B, Love C, et al. D2 collaborates with ID3 to suppress iNKT and innate-like tumors1. J Immunol. 2017;198:3136\u201348.","journal-title":"J Immunol"},{"issue":"13","key":"423_CR137","doi-asserted-by":"publisher","first-page":"493","DOI":"10.21873\/cgp.20012","volume":"11\u201312","author":"YU Kamata","year":"2016","unstructured":"Kamata YU, Sumida T, Kobayashi Y, Ishikawa A, Kumamaru W, Mori Y. Introduction of ID2 enhances invasiveness in ID2-null oral squamous cell carcinoma cells via the SNAIL axis. Cancer Genom Proteom. 2016;11\u201312(13):493\u20137.","journal-title":"Cancer Genom Proteom"},{"key":"423_CR138","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/s41419-020-2297-3","volume":"11","author":"ALS Cruz","year":"2020","unstructured":"Cruz ALS, Barreto EA, Fazolini NPB, Viola JPB, Bozza PT. Lipid droplets: platforms with multiple functions in cancer hallmarks. Cell Death Dis. 2020;11:105.","journal-title":"Cell Death Dis"},{"key":"423_CR139","doi-asserted-by":"publisher","DOI":"10.1007\/112_2020_51","volume-title":"Reviews in physiology, biochemistry and pharmacology","author":"T Petan","year":"2020","unstructured":"Petan T. Lipid droplets in cancer. In: Pedersen SHF, editor. Reviews in physiology, biochemistry and pharmacology. Berlin, Heidelberg: Springer; 2020. https:\/\/doi.org\/10.1007\/112_2020_51."},{"key":"423_CR140","doi-asserted-by":"publisher","first-page":"317","DOI":"10.3892\/or.2020.7826","volume":"45","author":"M Gantov","year":"2021","unstructured":"Gantov M, Pagnotta P, Lotufo C, Rindone GM, Riera MF, Calvo JC, et al. Beige adipocytes contribute to breast cancer progression. Oncol Rep. 2021;45:317\u201328.","journal-title":"Oncol Rep"},{"key":"423_CR141","doi-asserted-by":"publisher","first-page":"9247","DOI":"10.1158\/0008-5472.CAN-08-1343","volume":"68","author":"J Laurencikiene","year":"2008","unstructured":"Laurencikiene J, Stenson BM, Nordstrom EA, Agustsson T, Langin D, Isaksson B, et al. Evidence for an important role of CIDEA in human cachexia. Cancer Res. 2008;68:9247\u201354.","journal-title":"Cancer Res"},{"key":"423_CR142","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1086\/417048","volume":"66","author":"GC Williams","year":"1991","unstructured":"Williams GC, Nesse RM. The Dawn of Darwinian medicine. Q Rev Biol. 1991;66:1\u201322.","journal-title":"Q Rev Biol"},{"key":"423_CR143","doi-asserted-by":"crossref","DOI":"10.1093\/oso\/9780195060584.001.0001","volume-title":"Evolution of infectious disease","author":"PW Ewald","year":"1994","unstructured":"Ewald PW. Evolution of infectious disease. New York: Oxford University Press; 1994."},{"key":"423_CR144","doi-asserted-by":"publisher","DOI":"10.1126\/science.abi7661","author":"J Kaiser","year":"2021","unstructured":"Kaiser J. Special diets might boost the power of drugs to vanquish cancer. Science. 2021. https:\/\/doi.org\/10.1126\/science.abi7661.","journal-title":"Science"}],"container-title":["Infectious Agents and Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13027-022-00423-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13027-022-00423-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13027-022-00423-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,19]],"date-time":"2023-11-19T20:21:53Z","timestamp":1700425313000},"score":1,"resource":{"primary":{"URL":"https:\/\/infectagentscancer.biomedcentral.com\/articles\/10.1186\/s13027-022-00423-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,8]]},"references-count":144,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["423"],"URL":"https:\/\/doi.org\/10.1186\/s13027-022-00423-5","relation":{},"ISSN":["1750-9378"],"issn-type":[{"value":"1750-9378","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,8]]},"assertion":[{"value":"28 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"15"}}